ELTP Isradipine Results For Parkinson's Disease To
Post# of 2146
(Total Views: 649)
Posted On: 03/09/2019 11:21:48 AM
ELTP Isradipine Results For Parkinson's Disease To Be Announced
STEADY-PD III (isradipine) clinical trial results will be released at the 2019 American Academy of Neurology meeting in Philadephia on the 4th-10th May, 2019.
This Folks is for Parkinson's Disease.
ELTP and Teva are the two Manufacturers.
Results Announcement added to a Meeting.
Hmm, Would they do this for BAD Results?
I Think Not. Stay Tuned.
STEADY-PD III (isradipine) clinical trial results will be released at the 2019 American Academy of Neurology meeting in Philadephia on the 4th-10th May, 2019.
This Folks is for Parkinson's Disease.
ELTP and Teva are the two Manufacturers.
Results Announcement added to a Meeting.
Hmm, Would they do this for BAD Results?
I Think Not. Stay Tuned.
(0)
(0)Elite Pharmaceuticals Inc (ELTP) Stock Research Links
Scroll down for more posts ▼